comparemela.com
Home
Live Updates
Clinical Trials of Mavacamten in oHCM : comparemela.com
Clinical Trials of Mavacamten in oHCM
Milind Desai, MD, MBA, and Michelle M. Kittleson, MD, PhD, review the clinical trial data of mavacamten, the first FDA-approved cardiac myosin inhibitor for the treatment of oHCM.
Related Keywords
Anjali Owens ,
Milind Desai ,
Michellem Kittleson ,
James Januzzi ,
Twitter ,
Kansas City Cardiomyopathy Questionnaire ,
Obstructive Hypertrophic Cardiomyopathy ,
Johcm ,
Mavacamten ,
Cardiac Myosin Inhibitor ,
Clinical Trial Placebo ,
Biomarkers ,
Efficacy ,
Safety ,
Fda Approval ,
Class Ii ,
Valor Hcm Trial ,
comparemela.com © 2020. All Rights Reserved.